Fig. 1 · Structure
Documents & Downloads
Elocalcitol
VDR Agonist
Elocalcitol is a selective vitamin D receptor (VDR) agonist that demonstrates oral bioactivity. It exhibits significant anti-inflammatory properties and has been shown to inhibit the growth of prostate cancer cells. This compound serves as a valuable tool for research applications focused on the modulation of VDR activity and the exploration of novel therapeutic strategies for prostate cancer and inflammatory diseases.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 199798-84-0 |
| Applications | VDR Agonist |
| Formula | C29H43FO2 |
| Molecular Weight | 442.65 |
| Synonyms | BXL-628; Ro-26-9228 |
| SMILES | C[C@@]12[C@](CC=C2[C@@H](C)C/C=C/C(CC)(O)CC)([H])/C(CCC1)=C/C=C3C([C@H](C[C@@H](C\3)O)F)=C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.